UNSPSC 85533063: Supplement left common iliac vein with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left common iliac vein with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UD37Z

UNSPSC 85533063 Supplement left common iliac vein with autologous tissue substitute, percutaneous approach is a Commodity code that does not align with the state and local procurement activity reflected in recent opportunities. The code nominally describes a specific surgical vein-repair procedure using autologous tissue, yet the recent solicitations posted under this code cover occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent disability medical evaluations, surgical benefit carve-out programs, and emergency medical services for detained youth. None of these opportunities involve vein-repair procedures or the autologous tissue-substitution work the code's name indicates. The mismatch suggests either a data classification error in how opportunities were tagged to this code or a systemic divergence between the code's clinical scope and the administrative health-services work state and local buyers are actually sourcing under it.

The recent opportunities draw from state health agencies, county health systems, county human resources offices, and city retirement boards across Arizona, California, Florida, and Washington, signaling that the code as currently deployed captures a broad portfolio of occupational health, benefits administration, and clinical staffing sourcing rather than surgical procedure services. Without opportunities that actually reflect the code's intended clinical scope, pursuit of this code is not viable for firms offering vein-repair or autologous tissue-substitute services.